# Study of the Efficacy of N-acetylcysteine (NAC) on Impulse Control Disorders

> **NCT03146130** · PHASE3 · UNKNOWN · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 70 (estimated)

## Conditions studied

- Impulse Control Disorder
- Parkinson

## Interventions

- **BIOLOGICAL:** Variation of behaviors of Parkinson's disease

## Key facts

- **NCT ID:** NCT03146130
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-05
- **Primary completion:** 2019-12-20
- **Final completion:** 2019-12-20
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2018-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03146130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03146130, "Study of the Efficacy of N-acetylcysteine (NAC) on Impulse Control Disorders". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03146130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*